EUVIMEDEUVIMED entdecken
Crossref

Evaluation of PSMA target diagnostic PET tracers for therapeutic monitoring of [177Lu]ludotadipep of prostate cancer: Screening of PSMA target efficiency and biodistribution using [18F]DCFPyL and [68Ga]PSMA-11

Min Hwan Kim, Kyongkyu Lee, Keumrok Oh, Chul Hee Kim, Hee Seup Kil, Yong Jin Lee, Kyo Chul Lee, Dae Yoon Chi

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Min Hwan Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Radiopharmaceuticals, FutureChem Co. Ltd, Seoul, 04793, Republic of Korea. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, Korea Institute of Radiological and Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have compared the similarity of the in vivo distribution of the prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agents [18F]DCFPyL, [68Ga]galdotadipep, and [68Ga]PSMA-11. This study is designed for a further selection of a PSMA-targeted PET imaging agent for the therapeutic evaluation of [177Lu]ludotadipep, our previously developed prostate-specific membrane antigen (PSMA)-targeted prostate cancer therapeutic radiopharmaceutical. In vitro cell uptake was performed to evaluate the affinity to PSMA using PSMA + PC3-PIP, and PSMA- PC3-flu was used for the study. MicroPET/CT 60 min dynamic imaging and biodistribution were performed at 1, 2, and 4 h after injection. Autoradiography and immunohistochemistry were performed to evaluate the PSMA + tumor target efficiency. In the microPET/CT image, [68Ga]PSMA-11 showed the highest uptake in the kidney among all three compounds. [18F]DCFPyL and [68Ga]PSMA-11 showed similar patterns of in vivo biodistribution and high tumor targeting efficiency, similar to those of[68Ga]galdotadipep. All three agents showed high uptake in tumor tissue on autoradiography, and PSMA expression was confirmed by immunohistochemistry. Thus, [18F]DCFPyL or [68Ga]PSMA-11 can be used as a PET imaging agent to monitor [177Lu]ludotadipep therapy in prostate cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesProstatic NeoplasmsHumansMaleEarly Detection of CancerPositron-Emission TomographyRadiopharmaceuticalsTissue DistributionProstate-Specific AntigenLutetiumRadioisotopesFluorine Radioisotopes

Stichwörter der Autor:innen

MicroPET/CTProstate-specific membrane antigen (PSMA)[(177)Lu]Ludotadipep[(18)F]DCFPyL[(68)Ga]Galdotadipep[(68)Ga]PSMA-11

Substanzen

Gallium RadioisotopesRadiopharmaceuticalsProstate-Specific AntigenLutetium-177LutetiumRadioisotopesGallium-68Fluorine-18Fluorine Radioisotopes

Autor:innen und Institutionen

  • Research Institute of Radiopharmaceuticals, FutureChem Co. Ltd, Seoul, 04793, Republic of Korea.
  • Division of Applied RI, Korea Institute of Radiological & Medical Sciences, Seoul, 01812, Republic of Korea.
  • Research Institute of Radiopharmaceuticals, FutureChem Co. Ltd, Seoul, 04793, Republic of Korea. Electronic address: daeyoon.chi@futurechem.co.kr.

Förderung

  • Ministry of Science, ICT and Future Planning
  • Korea Institute of Radiological and Medical Sciences

Zitieren

APA

Kim, M. H., Lee, K., Oh, K., Kim, C. H., Kil, H. S., Lee, Y. J., Lee, K. C., & Chi, D. Y. (2023). Evaluation of PSMA target diagnostic PET tracers for therapeutic monitoring of [177Lu]ludotadipep of prostate cancer: Screening of PSMA target efficiency and biodistribution using [18F]DCFPyL and [68Ga]PSMA-11. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.02.003

Vancouver

Kim MH, Lee K, Oh K, Kim CH, Kil HS, Lee YJ, et al. Evaluation of PSMA target diagnostic PET tracers for therapeutic monitoring of [177Lu]ludotadipep of prostate cancer: Screening of PSMA target efficiency and biodistribution using [18F]DCFPyL and [68Ga]PSMA-11. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.02.003

BibTeX
@article{Kim2023,
  author = {Kim, Min Hwan and Lee, Kyongkyu and Oh, Keumrok and Kim, Chul Hee and Kil, Hee Seup and Lee, Yong Jin and Lee, Kyo Chul and Chi, Dae Yoon},
  title = {Evaluation of PSMA target diagnostic PET tracers for therapeutic monitoring of [177Lu]ludotadipep of prostate cancer: Screening of PSMA target efficiency and biodistribution using [18F]DCFPyL and [68Ga]PSMA-11},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.02.003}
}
Kostenlos starten →